Bollard, Catherine M.
- Baylor College of Medicine · Pediatrics (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #39,223
- Sustained Excellence
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2011 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pediatrics
NIH Funding · FY2023
Linked Award Amount
$195.7K
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#39,223
By linked amount among FY2023 PIs
Earliest Year Loaded
2011
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Bollard, Catherine M. as a PI. Multi-PI records show the full award amount for context.
- 5UG1HL108945-13UG1Contact PITargeting HIV and EBV Antigens in Patients with HIV LymphomaBaylor College of Medicine · Pediatrics (NIH department code)$195.7Kaward amount
Award organization
Organizations that administered FY2023 awards listing Bollard, Catherine M. as a PI.
FY2023 award administered by Baylor College of Medicine (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2011First NIH AwardBaylor College of Medicine
- 2011$500K Cumulative Funding
- 2011$1M Cumulative Funding
- 2011$2M Cumulative Funding
- 2011Entered Top 50% NationallyRanked #2007
- 2011Entered Top 25% NationallyRanked #2007
- 2012Entered Top 10% NationallyRanked #1978
- 2013$5M Cumulative Funding
- 2015$10M Cumulative Funding
- 2019Entered Top 5% NationallyRanked #811
- 2021$25M Cumulative Funding